MCK Q2 2022 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q2 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$66.6B+9.5% YoY

Gross Profit

$3.2B4.8% margin

Operating Income

$683M1.0% margin

Net Income

$267M0.4% margin

EPS (Diluted)

$1.71

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.7B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$63.6B

Total Liabilities

$63.7B

Stockholders' Equity

-$571M

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66.6B	$60.8B	+9.5%
Gross Profit	$3.2B	$2.9B	+12.9%
Operating Income	$683M	$804M	-15.0%
Net Income	$267M	$577M	-53.7%

Revenue Segments

U.S. Pharmaceutical Segment

$53.4B80%

International Segment

$9.1B14%

Medical-Surgical Solutions Segment

$3.1B5%

Prescription Technology Solutions

$932M1%